Product Description
GLS-5700 is a synthetic DNA plasmid vaccine against the Zika virus. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02887482)
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: GeneOne Life Science
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 1: Dengue|Pregnancy Outcomes|Zika Virus Infection|Microcephaly